L’Orphelin J-M, Lancien U, Nguyen J-M, Coronilla FJ, Saiagh S, Cassecuel J, et al. NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial. AO [Internet]. 2024 Nov. 7 [cited 2024 Nov. 23];63(1):867-7. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/40495